UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models

The FASEB journal, 2009-09, Vol.23 (9), p.2820-2830

2009

Volltextzugriff (PDF)

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

Experimental neurology, 2010-09, Vol.225 (1), p.210-218

2010

Volltextzugriff (PDF)

Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents

The Journal of clinical investigation, 2010-05, Vol.120 (5), p.1774-1785

2010

Volltextzugriff (PDF)

Dopamine D3 receptor antagonists as therapeutic agents

Drug discovery today, 2005-07, Vol.10 (13), p.917-925

2005

Volltextzugriff (PDF)

Insights on Foam Transport from a Texture-Implicit Local-Equilibrium Model with an Improved Parameter Estimation Algorithm

Industrial & engineering chemistry research, 2016-07, Vol.55 (28), p.7819-7829

2016

Volltextzugriff (PDF)

Neuroinflammation in Alzheimer's Disease and Parkinson's Disease: Are Microglia Pathogenic in Either Disorder?

International Review of Neurobiology, 2007-01, Vol.82 (3), p.235-246

2007

Volltextzugriff (PDF)

Higher Order Logic Theorem Proving and Its Applications: 6th International Workshop, HUG '93 Vancouver, B. C., Canada, August 11–13, 1993 Proceedings

1994

Volltextzugriff (PDF)

Microglial responses to dopamine in a cell culture model of Parkinson's disease

Neurobiology of aging, 2009-11, Vol.30 (11), p.1805-1817

2009

Volltextzugriff (PDF)

Dopamine D3 receptor agonists for protection and repair in Parkinson's disease

Current opinion in pharmacology, 2007-02, Vol.7 (1), p.100-105

2007

Volltextzugriff (PDF)

Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor

BMC biology, 2004-10, Vol.2 (1), p.22-22, Article 22

2004

Volltextzugriff (PDF)

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

Pharmacology & therapeutics (Oxford), 2001-05, Vol.90 (2-3), p.231-259

Joyce, J N

2001

Volltextzugriff (PDF)

c-Fos expression associated with reinstatement of cocaine-seeking behavior by response-contingent conditioned cues

Synapse (New York, N.Y.), 2009-10, Vol.63 (10), p.823-835

2009

Volltextzugriff (PDF)

Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists

Neurotoxicity research, 2003, Vol.5 (8), p.579-598

2003

Volltextzugriff (PDF)

Upregulation of Arc mRNA expression in the prefrontal cortex following cue-induced reinstatement of extinguished cocaine-seeking behavior

Synapse (New York, N.Y.), 2008-06, Vol.62 (6), p.421-431

2008

Volltextzugriff (PDF)

Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole

Experimental neurology, 2003-11, Vol.184 (1), p.393-407

2003

Volltextzugriff (PDF)

Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: Implications for cocaine-seeking behavior

Neuropsychopharmacology (New York, N.Y.), 2004-08, Vol.29 (8), p.1479-1487

2004

Volltextzugriff (PDF)

Developing a sustainable research culture in an independent academic medical center

The journal of research administration, 2013-03, Vol.44 (1), p.75

Joyce, Jeffrey N

2013

Volltextzugriff (PDF)

Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor

European journal of pharmacology, 2010-02, Vol.627 (1-3), p.167-172

2010

Volltextzugriff (PDF)

Modelling feature interactions in the automotive domain

International Conference on Software Engineering 2008, 2008, Vol.2008 (5), p.45-50

2008

Volltextzugriff (PDF)

Age-related differences in MK-801 induced behaviors in dopamine D3 receptor knock out mice

European journal of pharmacology, 2010-02, Vol.627 (1-3), p.177-184

2010

Volltextzugriff (PDF)

Substantia Nigra Marinesco Bodies Are Associated with Decreased Striatal Expression of Dopaminergic Markers

Journal of neuropathology and experimental neurology, 2004-04, Vol.63 (4), p.329-337

2004

Volltextzugriff (PDF)

Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E

Neuroscience letters, 2005-06, Vol.380 (3), p.252-256

2005

Volltextzugriff (PDF)

Dopamine D 3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

Pharmacology & therapeutics (Oxford), 2001-05, Vol.90 (2), p.231-259

Joyce, Jeffrey N.

2001

Volltextzugriff (PDF)

Bridging the Gap between ISO 26262 and Machine Learning: A Survey of Techniques for Developing Confidence in Machine Learning Systems

SAE International journal of advances and current practices in mobility, 2020-04, Vol.2 (3), p.1538-1550, Article 2020-01-0738

2020

Volltextzugriff (PDF)

Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice

Pharmacology, biochemistry and behavior, 2003-12, Vol.76 (3-4), p.551-562

2003

Volltextzugriff (PDF)

1 – 25 von 1.490

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.285)
Mit Volltextzugriff
(1.286)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(864)
Life Sciences & Biomedicine
(778)
Humans
(621)
Female
(378)
Male
(369)
Biological And Medical Sciences
(231)
Middle Aged
(219)
Animals
(198)
Adult
(183)
Aged
(177)
Medical Sciences
(163)
General & Internal Medicine
(109)
Neurosciences & Neurology
(107)
Adolescent
(82)
Neurosciences
(79)
Child
(76)
Fundamental And Applied Biological Sciences. Psychology
(76)
Medicine, General & Internal
(75)
Mice
(75)
Treatment Outcome
(69)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents

Dopamine D3 receptor antagonists as therapeutic agents

Insights on Foam Transport from a Texture-Implicit Local-Equilibrium Model with an Improved Parameter Estimation Algorithm

Neuroinflammation in Alzheimer's Disease and Parkinson's Disease: Are Microglia Pathogenic in Either Disorder?

Higher Order Logic Theorem Proving and Its Applications: 6th International Workshop, HUG '93 Vancouver, B. C., Canada, August 11–13, 1993 Proceedings

Microglial responses to dopamine in a cell culture model of Parkinson's disease

Dopamine D3 receptor agonists for protection and repair in Parkinson's disease

Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

c-Fos expression associated with reinstatement of cocaine-seeking behavior by response-contingent conditioned cues

Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists

Upregulation of Arc mRNA expression in the prefrontal cortex following cue-induced reinstatement of extinguished cocaine-seeking behavior

Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole

Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: Implications for cocaine-seeking behavior

Developing a sustainable research culture in an independent academic medical center

Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor

Modelling feature interactions in the automotive domain

Age-related differences in MK-801 induced behaviors in dopamine D3 receptor knock out mice

Substantia Nigra Marinesco Bodies Are Associated with Decreased Striatal Expression of Dopaminergic Markers

Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E

Dopamine D 3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

Bridging the Gap between ISO 26262 and Machine Learning: A Survey of Techniques for Developing Confidence in Machine Learning Systems

Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice

Suchergebnisse filtern